Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval

NCT02244151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Female Urogenital Diseases

Interventions

DRUG: Decapeptyl® diario
DRUG: Decapeptyl® daily

Sponsor

Instituto de Investigacion Sanitaria La Fe